CABIO Biotech (Wuhan) Co., Ltd.
公司專注于多不飽和脂肪酸 ARA、藻油DHA 及 SA、發酵來源β-胡蘿卜素等多個生物合成營養素產品的研發、生產與銷售20年。產品廣泛應用于嬰幼兒配方食品、膳食營養補充劑和健康食品、特殊醫學用途配方食品等領域。
CABIO Biotech (Wuhan) Co., Ltd （short for “CABIO” ） is a biotechnology-based company which combines technologies such as targeted optimization of industrial strains, precisely regulated fermentation and efficient separation and purification. Through sustainable microorganism fermentation, CABIO provides customers from nutrition and health industry worldwide with quality nutrient products and innovative solutions.
The Company has been focusing on R&D, manufacturing and sale of polyunsaturated fatty acid ARA, algal DHA oil, SA, natural-sourced β-carotene and other microorganism-fermented nutrient products for 20 years. Its products are widely applied in infant formula food，dietary supplements，healthy food, formula food for special medical purposes and other products.
On December 19, 2019, CABIO had its IPO on China’s Star Market successfully. It was the first food biotechnology company had its IPO on this Market as a high-tech based company.
“Providing safe, healthy and quality nutrient products and valuable solutions for customers and promoting public health through nutritional regulation” is always CABIO’s corporate mission.
CABIO will continue to focus on nutrition and health industry with technological innovation as the core driving force, constantly improve its operation level to international standard and actively participate in global competition so as to become a globally competitive biotechnology company featuring technological innovation which provides innovative natural-sourced nutrition products and solutions for customers from more regions and areas.